准线粒体:恢复耗尽的T细胞的抗瘤功效
Mei-Qi Yang1,2, Shu-Ling Zhang1,2, Li Sun1,2
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Molecular cancer
|November 20, 2024
概括
线粒体功能障碍导致T细胞耗尽,阻碍癌症免疫治疗. 本综述探讨了针对线粒体的策略,以恢复T细胞功能并提高癌症治疗疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 免疫检查点阻塞疗法在癌症治疗中表现有前途,但面临阻力.
- 功能失调的瘤透淋巴细胞,特别是T细胞,是抵抗的主要原因.
- 线粒体功能障碍是导致T细胞耗尽和抗瘤免疫力降低的关键因素.
研究的目的:
- 审查最近的线粒体向策略的进展,以恢复耗尽的T细胞功能.
- 突出线粒体健康在T细胞疲劳和免疫治疗反应中的作用.
- 为开发针对线粒体的新型癌症疗法提供基础.
主要方法:
- 关于T细胞耗尽中线粒体功能的当前文献的综述.
- 对针对T细胞代谢重塑,生物发生和抗氧化剂调节的策略的分析.
- 探索这些策略对T细胞功能和抗瘤功效的影响.
主要成果:
- 线粒体功能障碍会损害氧化酸化,并促进T细胞耗尽.
- 针对线粒体的策略可以通过改善代谢功能和减少氧化应激来逆转T细胞疲劳.
- 恢复线粒体功能可以提高癌症免疫疗法的疗效.
结论:
- 线粒体健康对于有效的T细胞功能在癌症免疫中至关重要.
- 准线粒体提供了一个有希望的治疗途径,以克服对免疫检查点封锁的抵抗力.
- 对线粒体向疗法的进一步研究可以显著推进癌症免疫疗法.
相关概念视频
Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitochondria
11.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


